| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 113908 | Null | 0.01456670152525 | 0.5474982 |
| NSC 225112 | 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- | 0.01456670152525 | 0.58578933 |
| NSC 266047 | 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) | 0.01456670152525 | 0.33601008 |
| NSC 3082 | s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) | 0.01456670152525 | 0.54017189 |
| NSC 30863 | Null | 0.01456670152525 | 0.42735881 |
| NSC 698955 | Null | 0.0149342570376736 | -0.078164498 |
| NSC 710552 | Null | 0.0149342570376736 | 0.32073355 |
| NSC 754664 | 3-amino-N-(5-chloro-2-methylphenyl)-5-oxo-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide | 0.0149342570376736 | 0.31387478 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 0.0162638908166157 | 0.54806658 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.0162638908166157 | 0.29284997 |